Factors Related to the Difference in Rates of Dengue Fever Cases
DOI:
https://doi.org/10.53861/lontarariset.v6i2.573Keywords:
Assurance claim, Dengue Hemorrhagic Fever, INA-CBGsAbstract
Dengue Hemorrhagic Fever (DHF) is an infectious disease caused by the Dengue virus and transmitted through the bite of the Aedes aegypti mosquito. The Bandung City Health Office said that this year as of April 26, 2024, the cumulative number of DHF cases in Bandung City exceeded 3,025 cases. This study aims to identify the factors associated between INA-CBGs tariffs and the actual treatment costs of Dengue Fever (DHF) patients at Hospital X Bandung. A correlation research method with a retrospective approach was used to analyze secondary data of JKN claims in 2023. The population in this study were patients who underwent inpatient treatment in 2023 at Hospital X Bandung with a diagnosis of Dengue Fever (DHF) with diagnosis code A91, totaling 906 medical record files. Samples were selected based on the criteria of medical record files with a primary diagnosis of Dengue Fever (DHF) and medical record files with JKN tariff setting. The results showed that length of stay (p < 0.001), medical procedures (p 0.018), and severity (p < 0.036) of illness significantly contributed to the tariff gap. This tariff gap has implications for the hospital's financial loss and potential reduction in service quality. Based on these findings, it is recommended to review the INA-CBGs tariff structure, develop clinical pathways, stricter management of treatment classes, and improve cooperation between hospitals and BPJS Kesehatan.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Bhisma Jaya Prasaja, Yoga Utomo, Yura Witsqa Firmansyah

This work is licensed under a Creative Commons Attribution 4.0 International License.
Lontara Journal Of Health Science And Technology is licensed under Creative Commons.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution 4.0 International (CC BY 4.0).
The Creative Commons Attribution 4.0 International (CC BY 4.0) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under “the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.